Stay updated on ARCHES-2 Study: ARO-ANG3 Clinical Trial
Sign up to get notified when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.

Latest updates to the ARCHES-2 Study: ARO-ANG3 Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.4 was added to the page and Revision: v3.3.3 was removed. This appears to be a minor metadata update that does not modify the study details, endpoints, or eligibility criteria.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check27 days agoChange DetectedAdded a comprehensive list of study locations across multiple regions (California, Florida, Minnesota, Nebraska, Nevada, New York, North Carolina, Ohio, Pennsylvania, Texas; New South Wales, Queensland; Ontario, Quebec) under Locations. Updated the revision tag from v3.3.2 to v3.3.3 and removed the prior version indicator.SummaryDifference1%

- Check41 days agoChange DetectedThe ARCHES-2 study record adds many new research sites worldwide and updates open-label extension timepoints and additional lipid endpoints.SummaryDifference2%

- Check48 days agoChange DetectedA new site revision label 'Revision: v3.3.2' appears and the previous 'Revision: v3.3.1' label is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check55 days agoChange DetectedPublications are now described as automatically filled from PubMed and may not be about the study. The page revision is updated to v3.3.1.SummaryDifference0.1%

- Check63 days agoChange DetectedRemoved the government funding lapse notice about page updates and NIH operating status from the study details page.SummaryDifference0.3%

Stay in the know with updates to ARCHES-2 Study: ARO-ANG3 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ARCHES-2 Study: ARO-ANG3 Clinical Trial page.